HomeFGEN • NASDAQ
add
FibroGen Inc
Previous close
$1.17
Day range
$1.05 - $1.18
Year range
$0.33 - $20.52
Market cap
113.59M USD
Avg Volume
1.80M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 27.14M | -21.03% |
Operating expense | 41.23M | -19.30% |
Net income | -56.23M | 15.03% |
Net profit margin | -207.21 | -7.61% |
Earnings per share | -0.57 | 18.57% |
EBITDA | -101.59M | -60.08% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 235.59M | -44.17% |
Total assets | 423.53M | -30.58% |
Total liabilities | 585.73M | -4.23% |
Total equity | -162.20M | — |
Shares outstanding | 98.77M | — |
Price to book | -0.57 | — |
Return on assets | -58.52% | — |
Return on capital | -813.66% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -56.23M | 15.03% |
Cash from operations | -18.32M | 65.11% |
Cash from investing | 10.24M | 837.05% |
Cash from financing | -246.00K | -100.51% |
Net change in cash | -7.23M | -2,679.23% |
Free cash flow | -34.10M | -484.56% |
About
Founded
Jan 1, 1993
Headquarters
Website
Employees
486